Experiment 584821
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | IV |
| Organism | Empty organism |
| Citation | GORDON,M: GURALNIK,M: KANEKO,Y: MIMURA,T: GOODGAME,J: LANG,W:. (1995). FURTHER CLINICAL STUDIES OF CURDLAN SULFATE (CRDS) - AN ANTI-HIV AGENT.. 26(3/4) |
| Amount utilized | |
| Compound isolated | |
| Disease | PHASE I STUDY OF EFFICACY IN INCREASING CD4 PATIENTS WITHOUT HIV-RELATED ILLNESS. ONLY SIDE EFFECT NOTED WAS INCREASE IN ACTIVATED PARTIAL THROMBOPLASTIN TIME. |
| Dose amount | 140.0 MG |
| Number | 1 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Per unit | PERSON |
| Dose expression | DOSE |